A Study to Assess Persistence, Adherence and Changes in Disease Activity in the Children Population of Juvenile Arthritis Patients Treated With Adalimumab (HUMIRA®)
Clinical trial NCT03383263 · COMPLETED
Trial details
- NCT number
- NCT03383263
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-05-04
- Primary completion
- 2020-09-14
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.